We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
(+10%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$127M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$20M |
| 3 |
Palantir
PLTR
|
+$18.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$16.7M |
| 5 |
Diageo
DEO
|
+$16.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$206M |
| 2 |
Meta Platforms (Facebook)
META
|
+$37.5M |
| 3 |
Amazon
AMZN
|
+$35.5M |
| 4 |
Broadcom
AVGO
|
+$34.8M |
| 5 |
Microsoft
MSFT
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.47% |
| 2 | Financials | 11.61% |
| 3 | Healthcare | 8.42% |
| 4 | Industrials | 6.72% |
| 5 | Consumer Discretionary | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
X4 Pharmaceuticals
XFOR
$423M
| $9.89K | ﹤0.01% |
5,203
+4,185
| +411% | +$17.1K |
|
|
SMCL
3977
GraniteShares 2x Long SMCI Daily ETF
SMCL
$40.9M
| $9.87K | ﹤0.01% |
81
-815
| -91% | -$69.7K |
|
3978
SuperCom
SPCB
$67.8M
| $9.86K | ﹤0.01% |
950
+372
| +64% | +$3.02K |
|
|
OPOF
3979
DELISTED
Old Point Financial
OPOF
| $9.85K | ﹤0.01% |
251
-29
| -10% | -$1.12K |
|
3980
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $9.77K | ﹤0.01% |
324
-2,820
| -90% | -$79.8K |
|
|
AUTL
3981
Autolus Therapeutics
AUTL
$620M
| $9.75K | ﹤0.01% |
4,277
-1,580
| -27% | -$2.61K |
|
3982
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
| $9.72K | ﹤0.01% |
+306
| New | +$9.42K |
|
|
AUUD
3983
Auddia
AUUD
$6.97M
| $9.66K | ﹤0.01% |
222
+183
| +469% | +$5.98K |
|
3984
Bridger Aerospace
BAER
$73.5M
| $9.62K | ﹤0.01% |
4,986
-394
| -7% | -$605 |
|
3985
Netcapital
NCPL
$2.75M
| $9.6K | ﹤0.01% |
+1,399
| New | +$3.47K |
|
3986
Cosan
CSAN
$2.54B
| $9.59K | ﹤0.01% |
1,899
-4,612
| -71% | -$24.9K |
|
|
HIVE
3987
HIVE Digital Technologies
HIVE
$725M
| $9.55K | ﹤0.01% |
+5,305
| New | +$9.35K |
|
|
TWFG
3988
TWFG Inc
TWFG
$353M
| $9.52K | ﹤0.01% |
+272
| New | +$9.07K |
|
|
WRD
3989
WeRide Inc
WRD
$2.08B
| $9.5K | ﹤0.01% |
+1,206
| New | +$10.8K |
|
3990
FibroBiologics
FBLG
$6.79M
| $9.47K | ﹤0.01% |
761
+282
| +59% | +$5.09K |
|
|
PPIH
3991
Perma-Pipe International
PPIH
$212M
| $9.45K | ﹤0.01% |
413
+396
| +2,329% | +$5.71K |
|
3992
PSQ Holdings
PSQH
$13.5M
| $9.41K | ﹤0.01% |
306
-952
| -76% | -$29.1K |
|
|
MRSN
3993
DELISTED
Mersana Therapeutics
MRSN
| $9.38K | ﹤0.01% |
1,267
+220
| +21% | +$1.93K |
|
3994
Q32 Bio
QTTB
$460M
| $9.31K | ﹤0.01% |
6,252
+3,075
| +97% | +$5.24K |
|
|
VERO
3995
DELISTED
Venus Concept
VERO
| $9.29K | ﹤0.01% |
3,921
+2,139
| +120% | +$5.68K |
|
3996
BioAtla
BCAB
$5.78M
| $9.23K | ﹤0.01% |
+466
| New | +$9.45K |
|
|
TBRG
3997
DELISTED
TruBridge
TBRG
| $9.2K | ﹤0.01% |
393
-613
| -61% | -$15K |
|
|
GCTS
3998
GCT Semiconductor Holding
GCTS
$190M
| $9.2K | ﹤0.01% |
6,172
+576
| +10% | +$777 |
|
3999
Defiance Quantum ETF
QTUM
$5.63B
| $9.18K | ﹤0.01% |
100
+95
| +1,900% | +$7.68K |
|
|
HPE.PRC
4000
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
$4.21B
| $9.07K | ﹤0.01% |
154
-669
| -81% | -$33.8K |
|
Similar funds
CA
BHC
ICP
AP
BWA
BOK
JSW
SP
Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review
As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
- Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
- Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
- Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
- Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
- Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.